Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

Elderly woman receiving a vaccination

Based on data from 1.14 million vaccinations which have been administered, scientists from the University of Edinburgh have shown that both the BioNtech/Pfizer and Oxford vaccines are highly effective and that by the fourth week after receiving the initial dose shown to reduce the risk of hospitalisation from COVID-19 by up to 85% and 94%, respectively.

They report that by the fourth week after receiving the initial vaccination, those aged 80 years and over were shown to have an 81% reduction in hospitalisation risk, a combined result for data from those vaccinated with either the Oxford or BionTech/Pfizer vaccines.

Read the full story on the University of Oxford website.